Skip to content

Medical-device intelligence

OVK: Cytokeratin Fragments 21-1 Eia Kit

FDA product code OVK: Cytokeratin Fragments 21-1 Eia Kit. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
OVK
FDA device name
Cytokeratin Fragments 21-1 Eia Kit
Device class
2
Regulation number
866.6010
Medical specialty
Immunology
Review panel
IM

FDA definition

The CYFRA 21-1 EIA kit is intended for the quantitative determination of soluble cytokeratin 19 fragments in human serum. The assay is to be used as an aid in monitoring disease progression during the course of disease and treatment in lung cancer patients. Serial testing for patient CYFRA 21-1 assay values should be used in conjunction with other clinical methods used for monitoring lung cancer.
Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

3 clearance records and 0 recall records in the covered releases, across 2 source company names and 1 product codes. Dated history runs from May 26, 2011 to Dec 16, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202510
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
OVK · Cytokeratin Fragments 21-1 Eia Kit30

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

3 matching records
Device / recordCompany in FDA recordSourceSource date
ADVIA Centaur Cytokeratin Fragment 21-1K250925 · OVKFujirebio Diagnostics,Inc.510(k)Dec 16, 2025FDA decision date
Elecsys CYFRA 21-1, Elecsys CYFRA 21-1 CalSet, PreciControl Tumor MarkerK160915 · OVKRoche Diagnostics510(k)Dec 14, 2016FDA decision date
CYFRA 21-1 EIA MODEL 211-10K100831 · OVKFujirebio Diagnostics,Inc.510(k)May 26, 2011FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗